Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93227817 | 9322781 | 7 | F | 201212 | 20160721 | 20130601 | 20160725 | EXP | CA-ROCHE-1230056 | ROCHE | 66.74 | YR | F | Y | 59.00000 | KG | 20160725 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93227817 | 9322781 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 400 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 392 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 386.4 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 408 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 417.6 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 406 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 418 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 8 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 442 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 9 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 436 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 10 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 440 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 11 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 458.4 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 12 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 468 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 13 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 442 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 14 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 472 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 15 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 492 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 93227817 | 9322781 | 16 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 493.6 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 93227817 | 9322781 | 17 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 496.6 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 93227817 | 9322781 | 18 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 492 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 19 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 472 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 20 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 488.8 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 21 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125276 | 489 | MG | SOLUTION FOR INFUSION | |||||||
| 93227817 | 9322781 | 22 | SS | RIVOTRIL | CLONAZEPAM | 1 | Unknown | U | 17533 | ||||||||||
| 93227817 | 9322781 | 23 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 93227817 | 9322781 | 24 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 25 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 26 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 27 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 28 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 29 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 30 | C | STATEX (CANADA) | MORPHINE SULFATE | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 31 | C | IMOVANE | ZOPICLONE | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 32 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 33 | C | GRAVOL | DIMENHYDRINATE | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 34 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 93227817 | 9322781 | 35 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93227817 | 9322781 | 1 | Rheumatoid arthritis |
| 93227817 | 9322781 | 22 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93227817 | 9322781 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93227817 | 9322781 | Bronchitis | |
| 93227817 | 9322781 | Cardiac failure | |
| 93227817 | 9322781 | Cystitis | |
| 93227817 | 9322781 | Dizziness | |
| 93227817 | 9322781 | Drug effect decreased | |
| 93227817 | 9322781 | Emphysema | |
| 93227817 | 9322781 | Fall | |
| 93227817 | 9322781 | General physical health deterioration | |
| 93227817 | 9322781 | Nausea | |
| 93227817 | 9322781 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 93227817 | 9322781 | 1 | 20101229 | 0 | ||
| 93227817 | 9322781 | 2 | 20110203 | 0 | ||
| 93227817 | 9322781 | 3 | 20110307 | 0 | ||
| 93227817 | 9322781 | 4 | 20110419 | 0 | ||
| 93227817 | 9322781 | 5 | 20110517 | 0 | ||
| 93227817 | 9322781 | 6 | 20110719 | 0 | ||
| 93227817 | 9322781 | 7 | 20110831 | 0 | ||
| 93227817 | 9322781 | 8 | 20110928 | 0 | ||
| 93227817 | 9322781 | 9 | 20111019 | 0 | ||
| 93227817 | 9322781 | 10 | 20111123 | 0 | ||
| 93227817 | 9322781 | 11 | 20120104 | 0 | ||
| 93227817 | 9322781 | 12 | 20120201 | 0 | ||
| 93227817 | 9322781 | 13 | 20120411 | 0 | ||
| 93227817 | 9322781 | 14 | 20120601 | 0 | ||
| 93227817 | 9322781 | 15 | 20120629 | 0 | ||
| 93227817 | 9322781 | 16 | 20120810 | 0 | ||
| 93227817 | 9322781 | 17 | 20120927 | 0 | ||
| 93227817 | 9322781 | 18 | 20121116 | 0 | ||
| 93227817 | 9322781 | 19 | 20130125 | 0 | ||
| 93227817 | 9322781 | 20 | 20130222 | 0 | ||
| 93227817 | 9322781 | 21 | 20130606 | 20131108 | 0 |